Low acuity dressing with integral pump

US11246975B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11246975-B2
Application numberUS-201615571238-A
CountryUS
Kind codeB2
Filing dateMay 8, 2016
Priority dateMay 8, 2015
Publication dateFeb 15, 2022
Grant dateFeb 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, assemblies, and methods for providing negative-pressure therapy to a tissue site are described. The system can include an absorbent and a sealing layer configured to cover the absorbent. The system can also include a blister fluidly coupled to the absorbent. The blister may have a collapsed position and an expanded position. A first check valve may be fluidly coupled to the absorbent and the blister and configured to prevent fluid flow from the blister into the absorbent if the blister is moved from the expanded position to the collapsed position. A second check valve may be fluidly coupled to the blister and the ambient environment and configured to prevent fluid flow from the ambient environment into the blister if the blister is moved from the collapsed position to the expanded position.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for providing negative-pressure therapy to a tissue site, the system comprising: an absorbent; a sealing layer configured to cover the absorbent, the sealing layer having a periphery extending beyond an edge of the absorbent; a blister having flexible walls and fluidly coupled to the absorbent, the blister having a collapsed position and an expanded position, the blister coupled to a top portion of the periphery of the sealing layer; a foam block disposed in the blister, the foam block having a compressive force deflection greater than a compressive force deflection of a tissue interface configured to be positioned between the tissue site and the absorbent; a first conduit configured to fluidly couple the blister to the absorbent; a second conduit configured to fluidly couple the blister to the ambient environment; a first check valve disposed in the first conduit and configured to prevent fluid flow from the blister into the absorbent if the blister is moved from the expanded position to the collapsed position; and a second check valve disposed in the second conduit and configured to prevent fluid flow from the ambient environment into the blister if the blister is moved from the collapsed position to the expanded position. 2. The system of claim 1 , wherein: the absorbent is coupled to the sealing layer; and the first conduit fluidly couples the absorbent to the blister through the sealing layer. 3. The system of claim 1 , wherein the periphery of the sealing layer further comprises: a barrier layer; a bonding adhesive layer coupled to the barrier layer; and a sealing adhesive layer having a plurality of apertures and coupled to the barrier layer, the bonding adhesive layer configured to extend at least partially through the plurality of apertures in the sealing adhesive layer in response to force applied to the barrier layer. 4. The system of claim 3 , wherein the bonding adhesive layer and the sealing adhesive layer are registered with each other. 5. The system of claim 3 , wherein the sealing adhesive layer is coupled to the bonding adhesive layer. 6. The system of claim 1 , further comprising a filter disposed in a fluid path between the first check valve and the blister. 7. The system of claim 6 , wherein the filter comprises a hydrophobic porous polymer. 8. The system of claim 6 , wherein the filter includes gel-blocking properties. 9. The system of claim 1 , wherein the blister has a larger volume than a combined volume of the absorbent and the tissue interface. 10. The system of claim 1 , further comprising an upstream layer and a downstream layer, the absorbent configured to be positioned between the upstream layer and the downstream layer. 11. The system of claim 10 , wherein the upstream layer and the downstream layer each have a hydrophobic side and a hydrophilic side, wherein the hydrophilic side is configured to acquire fluid from the hydrophobic side and assist in moving the fluid into the absorbent. 12. The system of claim 1 , wherein the periphery of the sealing layer forms a foundational flange on a first side of the absorbent and a sealing flange on a second side of the absorbent. 13. The system of claim 12 , wherein the blister comprises a film layer configured to be coupled to the foundational flange and form a source cavity, the foam block configured to be disposed in the source cavity. 14. The system of claim 13 , wherein the film layer comprises a source flange configured to couple the film layer to the foundational flange. 15. A method for providing negative-pressure therapy to a tissue site, the method comprising: positioning a dressing assembly adjacent to the tissue site, the dressing assembly having: an absorbent; a sealing layer configured to cover the absorbent, the sealing layer having a periphery extending beyond an edge of the absorbent; a blister fluidly coupled to the absorbent, the blister having a collapsed position and an expanded position, the blister comprising a source cavity and a foam block disposed in the source cavity, the foam block configured to bias the blister, the blister coupled to a top portion of the periphery of the sealing layer; wherein the foam block has a compressive force deflection greater than a compressive force deflection of a tissue interface configured to be positioned between the tissue site and the sealing layer; a first tube configured to fluidly couple the blister to the absorbent; a second tube configured to fluidly couple the blister to the ambient environment; a first check valve disposed in the first tube and configured to prevent fluid flow from the blister into the absorbent if the blister is moved from the expanded position to the collapsed position; and a second check valve disposed in the second tube and configured to prevent fluid flow from the ambient environment into the blister if the blister is moved from the collapsed position to the expanded position; collapsing the blister from the expanded position to the collapsed position to evacuate the blister; and expanding the blister from the collapsed position to the expanded position to draw fluid from the absorbent. 16. The method of claim 15 , further comprising indicating that a pressure at the absorbent is about a therapy pressure. 17. The method of claim 16 , wherein indicating that a pressure at the absorbent is about the therapy pressure comprises: collapsing the blister from the expanded position to the collapsed position to evacuate the blister; and maintaining the blister in the collapsed position.

Assignees

Inventors

Classifications

  • having a bridging element for transferring the reduced pressure from the connector to the dressing · CPC title

  • the dressing itself forming the collection container · CPC title

  • Containers specifically adapted for negative pressure wound therapy · CPC title

  • A61M1/68Primary

    Containers incorporating a flexible member creating suction · CPC title

  • Containers for suction drainage, adapted to be used with an external suction source (containers not adapted for subjection to vacuum A61M1/69) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11246975B2 cover?
Systems, assemblies, and methods for providing negative-pressure therapy to a tissue site are described. The system can include an absorbent and a sealing layer configured to cover the absorbent. The system can also include a blister fluidly coupled to the absorbent. The blister may have a collapsed position and an expanded position. A first check valve may be fluidly coupled to the absorbent a…
Who is the assignee on this patent?
Kci Licensing Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/68. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).